Cited by 255Cardiac Valve Diseases and TreatmentsCardiac Imaging and DiagnosticsAortic Disease and Treatment Approaches

The Prevalence, Incidence, Progression, and Risks of Aortic Valve Sclerosis

Open access
Coffey, Sean, Cox, Brian, Williams, Michael J.A.·2014·Journal of the American College of Cardiology

Abstract

Objectives The aim of this study was to comprehensively review the epidemiology of aortic sclerosis (ASc) and its association with cardiovascular events.Background ASc, which is defined as thickening or calcification of the aortic valve without significant obstruction of blood flow, is a common finding on cardiac imaging.Methods We searched MEDLINE and EMBASE from inception to April 2013 for studies describing the epidemiology of ASc and performed a meta-analysis of the risk of adverse events using a random effects model.Results Twenty-two studies were identified from the systematic review. The prevalence of ASc increased in proportion to the average age of study participants, ranging from 9% in a study in which the mean age was 54 years to 42% in a study in which the mean age was 81 years. In total, 1.8% to 1.9% of participants with ASc had progression to clinical aortic stenosis per year. There was a 68% increased risk of coronary events in subjects with ASc (hazard ratio [HR]: 1.68; 95% confidence interval [CI]: 1.31 to 2.15), a 27% increased risk of stroke (HR: 1.27; 95% CI: 1.01 to 1.60), a 69% increased risk of cardiovascular mortality (HR: 1.69; 95% CI: 1.32 to 2.15), and a 36% increased risk of all-cause mortality (HR: 1.36; 95% CI: 1.17 to 1.59).Conclusions ASc is a common finding that is more prevalent with older age. Despite low rates of progression to ASc, there is an independent increase in morbidity and mortality associated with the condition.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jacc.2014.04.018

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Among people with aortic sclerosis, progression to aortic stenosis occurs at a rate of 1.8-1.9% of patients per year.

    “According to a recent meta-analysis, the rate of progression to AS in individuals with aortic sclerosis is 1.8–1.9% of patients per year11.”

    From Calcific aortic stenosis (2016) · cites this paper as [11]

  • When lifespan or quality of life is profoundly limited by frailty, noncardiac disease, or mental or physical disability, the potential benefit of aortic valve replacement may be low.

    “Therefore, when lifespan or quality of life is profoundly limited by frailty, noncardiac disease, mental or physical disability, the potential benefit of AVR may be low11.”

    From Calcific aortic stenosis (2016) · cites this paper as [11]

    The Significance of Aortic Valve Sclerosis section discusses cardiovascular risk and treatment of other risk factors in people with at least five years’ life expectancy, not the benefit of aortic valve replacement. Searches for frailty, disability, quality of life, and valve replacement found no passage addressing the claimed circumstances in which AVR may offer little benefit. The indexed passages provide no page numbers. (LLM, conf=0.76)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 6

  1. [10]10. Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000;283:2008-12.
  2. [11]11. The Nordic Cochrane Centre. Review Manager (RevMan). Copen- hagen: The Cochrane Collaboration; 2012.
  3. [13]13. Kaelsch H, Lehmann N, Moehlenkamp S, et al. Prevalence of aortic and mitral valvular calcification as a marker of atherosclerosis for improved cardiovascular risk prediction assessed by computed tomog- raphy. Eur Heart J 2011;32:222.
  4. [15]15. Messika-Zeitoun D, Bielak LF, Peyser PA, et al. Aortic valve calcifi- cation: determinants and progression in the population. Arterioscler Thromb Vasc Biol 2007;27:642-8.
  5. [18]18. Lowery C, Frenneaux M, Dawson D, et al. Prevalence of previously undiagnosed aortic and mitral valve disease in a community population over the age of 60. Eur Heart J Cardiovasc Imaging 2012;13:i18.
  6. [24]24. Coffey et al. JACC Vol. 63, No. 25, 2014 Significance of Aortic Valve Sclerosis July 1, 2014:2852-61

Cited by

Sorted by citations

Authors
Coffey, S., Cox, B., & Williams, M. J. A.
Affiliations
  • University of Oxford (GB)
  • University of Otago (NZ)
Corresponding author
Coffey, Sean
Venue
Journal of the American College of Cardiology
Publisher
Elsevier BV
Published
2014-07
Volume
63
Issue
25
Pages
2852-2861
ISSN
0735-1097 (ISSN-L)
OpenAlex
W95580629
Cited by
255
References
41
Citations by year
2026: 17 · 2025: 33 · 2024: 25 · 2023: 26 · 2022: 20 · 2021: 33 · 2020: 18 · 2019: 26 · 2018: 15 · 2017: 16 · 2016: 9 · 2015: 14 · 2014: 3
FWCI
9.60
Type
journal article
Language
en
Open access
Locations
  • Journal of the American College of Cardiology (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Tony Hocken Scholarship
  • Director's Cancer Research Trust
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Valve Diseases and Treatments
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Cardiac Imaging and Diagnostics
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Aortic Disease and Treatment Approaches
Keywords
aortic valve sclerosis, aortic valve calcification, prevalence, incidence, disease progression, aortic stenosis, cardiovascular mortality, stroke, coronary events, all-cause mortality, age-related prevalence, cardiovascular risk
MeSH terms
Aortic Valve Stenosis, Heart Rate, Humans, Prognosis, Risk Factors, Global Health, Incidence, Prevalence, Disease Progression

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review